H.R. 5993 · 109th Congress
To amend the Federal Food, Drug, and Cosmetic Act to prohibit the marketing of authorized generic drugs.
- Stage
- In committee
- Sponsor
- Jo Ann Emerson
- Introduced
- 2006-07-28
- Latest action
- 2006-08-01 · Referred to the Subcommittee on Health.
Summary
Amends the Federal Food, Drug, and Cosmetic Act to prohibit a holder of a new, approved drug application from manufacturing, marketing, selling, or distributing a generic version of such drug during any exclusivity period granted to manufacturers of generic brands.